Shanghai Sanyou (China) Performance
688085 Stock | 18.07 0.07 0.39% |
The entity has a beta of 0.32, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Shanghai Sanyou's returns are expected to increase less than the market. However, during the bear market, the loss of holding Shanghai Sanyou is expected to be smaller as well. At this point, Shanghai Sanyou Medical has a negative expected return of -0.11%. Please make sure to validate Shanghai Sanyou's mean deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if Shanghai Sanyou Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Shanghai Sanyou Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Begin Period Cash Flow | 387.9 M |
Shanghai |
Shanghai Sanyou Relative Risk vs. Return Landscape
If you would invest 1,951 in Shanghai Sanyou Medical on December 26, 2024 and sell it today you would lose (151.00) from holding Shanghai Sanyou Medical or give up 7.74% of portfolio value over 90 days. Shanghai Sanyou Medical is generating negative expected returns and assumes 2.5195% volatility on return distribution over the 90 days horizon. Simply put, 22% of stocks are less volatile than Shanghai, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Shanghai Sanyou Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Shanghai Sanyou's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Shanghai Sanyou Medical, and traders can use it to determine the average amount a Shanghai Sanyou's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0437
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | 688085 |
Estimated Market Risk
2.52 actual daily | 22 78% of assets are more volatile |
Expected Return
-0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Shanghai Sanyou is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Shanghai Sanyou by adding Shanghai Sanyou to a well-diversified portfolio.
Shanghai Sanyou Fundamentals Growth
Shanghai Stock prices reflect investors' perceptions of the future prospects and financial health of Shanghai Sanyou, and Shanghai Sanyou fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Shanghai Stock performance.
Return On Equity | 0.0055 | ||||
Return On Asset | 0.0103 | ||||
Profit Margin | 0.03 % | ||||
Operating Margin | (0.06) % | ||||
Current Valuation | 4.47 B | ||||
Shares Outstanding | 277.88 M | ||||
Price To Book | 2.62 X | ||||
Price To Sales | 11.17 X | ||||
Revenue | 460.39 M | ||||
EBITDA | 39.16 M | ||||
Total Debt | 4.15 M | ||||
Book Value Per Share | 7.69 X | ||||
Cash Flow From Operations | 267.43 M | ||||
Earnings Per Share | 0.14 X | ||||
Total Asset | 2.26 B | ||||
Retained Earnings | 581.46 M | ||||
About Shanghai Sanyou Performance
By analyzing Shanghai Sanyou's fundamental ratios, stakeholders can gain valuable insights into Shanghai Sanyou's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Shanghai Sanyou has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Shanghai Sanyou has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Shanghai Sanyou Medical performance evaluation
Checking the ongoing alerts about Shanghai Sanyou for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Shanghai Sanyou Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Shanghai Sanyou generated a negative expected return over the last 90 days | |
About 44.0% of the company shares are owned by insiders or employees |
- Analyzing Shanghai Sanyou's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Shanghai Sanyou's stock is overvalued or undervalued compared to its peers.
- Examining Shanghai Sanyou's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Shanghai Sanyou's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Shanghai Sanyou's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Shanghai Sanyou's stock. These opinions can provide insight into Shanghai Sanyou's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Shanghai Stock analysis
When running Shanghai Sanyou's price analysis, check to measure Shanghai Sanyou's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Sanyou is operating at the current time. Most of Shanghai Sanyou's value examination focuses on studying past and present price action to predict the probability of Shanghai Sanyou's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Sanyou's price. Additionally, you may evaluate how the addition of Shanghai Sanyou to your portfolios can decrease your overall portfolio volatility.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |